Dhanuka Agritech Limited — PPTs, 31-10-2025: Investor Presentation

Dhanuka Agritech's Q2 FY26 revenue dipped to Rs 598.25 Cr (-8.56% YoY) with PAT at Rs 93.97 Cr (-20.04% YoY). This was largely due to abnormal rainfall impacting crop health and reducing agrochemical demand.

The company's strategy focuses on a robust pipeline of "9(3) products" and global innovator partnerships, bringing new tech to Indian farms via an extensive distribution network for over 10 million farmers. Recent wins include the registration for Ipflufenoquin (collaboration with Nisso Chemicals, Japan) for paddy, and trial production of a second product at the Dahej plant, with Bifenthrin sales on track.

For FY26, management anticipates flat revenue growth and an EBITDA decline of around 100bps. The company remains committed to farmer welfare and new product development for future expansion.